Airway eosinophilia and expression of interleukin‐5 protein in asthma and in exacerbations of chronic bronchitis
- 1 July 1996
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 26 (7) , 766-774
- https://doi.org/10.1111/j.1365-2222.1996.tb00606.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 1993
- Eosinophilia in early-stage human immunodeficiency virus infectionJournal of Allergy and Clinical Immunology, 1993
- Allergen exposure induces the activation of allergen‐specific Th2 cells in the airway mucosa of patients with allergic respiratory disordersEuropean Journal of Immunology, 1993
- Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthmaJournal of Allergy and Clinical Immunology, 1992
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Recombinant human interleukin 5 is a selective activator of human eosinophil function.The Journal of Experimental Medicine, 1988
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986
- Time course of the increase in airway responsiveness associated with late asthmatic reactions to toluene diisocyanate in sensitized subjectsJournal of Allergy and Clinical Immunology, 1985
- A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysemaThorax, 1969